This website uses cookies to understand how you use the website and to improve your experience. By continuing to use the website, you accept the University of New England’s use of cookies and similar technologies. To learn more about our use of cookies and how to manage your browser cookie settings, please review our Privacy Notice.


John Redwanski

Dr. John Redwanski received is Bachelor of Science degree in finance from Ball State University and his Doctor of Pharmacy degree from Purdue University. He subsequently completed a specialized residency in drug information at Nova Southeastern University.

John worked as director of drug information at Hampton University for five years before joining UNE in 2009. He now acts as the student ASHP liaison and is involved in the national and state ASHP chapters. John has garnered the Preceptor of the Year award in 2007 and 2008. His research interests are pharmacognosy, clinical trial bias, and complementary alternative medicines where he is a member of the editorial board for Natural Medicines and American Journal of Pharmaceutical Education.


Bachelor of Science, Finance & Insurance

Ball State University

Doctor of Pharmacy

Purdue University

Board Certifications and Licenses

Maine Board of Pharmacy license


Drug information

Nova Southeastern University

Fort Lauderdale


Clinical Affiliations

Clinic Name





Drug Information

Complementary alternative medicines

Holistic Health



Selected Publications

Redwanski J. "Incorporating team-based learning in a drug information course covering tertiary literature" Currents in Pharmacy Teaching & Learning, 2012; 4 (2): 202 - 206.

Redwanski J, Brazeau GA. "Much More Than Just an Interview" Am J Pharm Educ, 2012; 76 (2) Article 18.

Redwanski J. "Is Universal Healthcare in Our Future?" Journal of Best Practices in Health Professions Diversity, Fall 2007; 1 (2): 65 - 71.

Wilkerson D., Redwanski J. "Can ASHP's 2015 Goals be Achieved?" Drug Topics, 2007; 151 (13): 36.

Redwanski J. "Impact of Counterfeit Drugs on the Formulary Decision-Making Process" Formulary (USA), 2004; 39: 577 - 579,583.

John Redwanski

John Redwanski


B.S., Pharm.D.

Associate Professor, Director of Drug Information

Pharmacy Building

(207) 221-4156

On Campus